Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Aurora kinase A (AURKA) |
Target Info
|
Inhibitor |
[2] |
| References |
Top |
| REF 1 |
ClinicalTrials.gov (NCT03092934) A Study of AK-01 (LY3295668) in Solid Tumors. U.S. National Institutes of Health.
|
| REF 2 |
Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy. Mol Cancer Ther. 2019 Dec;18(12):2207-2219.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
